We are live on ! Find out more
MBOT icon

Microbot Medical

29 hedge funds and large institutions have $910K invested in Microbot Medical in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

12% more funds holding

Funds holding: 2629 (+3)

3.99% more ownership

Funds ownership: 0.21%4.19% (+4%)

7% less capital invested

Capital invested by funds: $974K → $910K (-$64K)

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
11
Reduced
4
Closed
8
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q3 2018 in Review

29 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2018, worth a combined $910K — down 6.6% from $974K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBOT positions and 8 closed out — a net gain of 3 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Sabby Management, adding an estimated $186K. The largest seller was Virtu Financial, exiting entirely with an estimated $57K sold.

  • 29 institutional investors held Microbot Medical (MBOT) as of Q3 2018, up from 26 in Q2 2018.
  • Funds reported $910K of Microbot Medical stock for Q3 2018, down 6.6% quarter-over-quarter.
  • 11 funds opened new Microbot Medical positions in Q3 2018 and 8 closed out, a net change of +3 holders.
  • The largest Microbot Medical buyer in Q3 2018 was Sabby Management, an estimated $186K added.
  • The largest Microbot Medical seller in Q3 2018 was Virtu Financial, an estimated $57K sold.

Based on aggregated 13F filings for Q3 2018.